FREE SHIPPING ON ORDERS OVER $150

gorilla healing tirzepatide Injectable | Compounded GLP-1/GIP FDA Approves Tirzepatide, A Potential

$21.96

Quantity
- +
Description

Trulicity is a prescription medication used to treat type 2 diabetes. It is in the class of drugs called GLP-1 receptor agonists and works by stimulating the release of insulin and decreasing the production of sugar by the liver. The pre-filled pens come in a pack of 4 and contain a solution of dulaglutide, the active ingredient, in a concentration of 1.5 mg per 0.5 mL. These pens are used to inject Trulicity subcutaneously (under the skin) once a week and are intended for single-use only. They are convenient and easy to use, allowing patients to self-administer their medication at home

gorilla healing tirzepatide Injectable | Compounded GLP-1/GIP FDA Approves Tirzepatide, A Potential

Synedica Tirzepatide 40mg Pen is a high-purity dual-pathway peptide researched for appetite control, metabolic support, and advanced weight-loss applications.

gorilla healing tirzepatide Injectable | Compounded GLP-1/GIP FDA Approves Tirzepatide, A Potential

Learn what to do if you missed a Mounjaro dose, and how to safely restart your GLP-1 treatment after a break in our expert guide.

gorilla healing tirzepatide Injectable | Compounded GLP-1/GIP FDA Approves Tirzepatide, A Potential

It is a deliberate attempt to make untested compounds appear familiar, safe, and appropriate for routine human use

gorilla healing tirzepatide Injectable | Compounded GLP-1/GIP FDA Approves Tirzepatide, A Potential

Doctor-prescribed compounded semaglutide, delivered to your door

gorilla healing tirzepatide Injectable | Compounded GLP-1/GIP FDA Approves Tirzepatide, A Potential

You may also like

recommand products